• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在致死性 COVID-19 患者中的病毒存在和免疫病理学:一项前瞻性尸检队列研究。

Viral presence and immunopathology in patients with lethal COVID-19: a prospective autopsy cohort study.

机构信息

Department of Pathology, Amsterdam University Medical Centers (UMC), VU University Amsterdam, Amsterdam, Netherlands.

Department of Intensive Care Medicine, Amsterdam UMC, University of Amsterdam, Amsterdam, Netherlands.

出版信息

Lancet Microbe. 2020 Nov;1(7):e290-e299. doi: 10.1016/S2666-5247(20)30144-0. Epub 2020 Sep 25.

DOI:10.1016/S2666-5247(20)30144-0
PMID:33015653
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7518879/
Abstract

BACKGROUND

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) targets multiple organs and causes severe coagulopathy. Histopathological organ changes might not only be attributable to a direct virus-induced effect, but also the immune response. The aims of this study were to assess the duration of viral presence, identify the extent of inflammatory response, and investigate the underlying cause of coagulopathy.

METHODS

This prospective autopsy cohort study was done at Amsterdam University Medical Centers (UMC), the Netherlands. With informed consent from relatives, full body autopsy was done on 21 patients with COVID-19 for whom autopsy was requested between March 9 and May 18, 2020. In addition to histopathological evaluation of organ damage, the presence of SARS-CoV-2 nucleocapsid protein and the composition of the immune infiltrate and thrombi were assessed, and all were linked to disease course.

FINDINGS

Our cohort (n=21) included 16 (76%) men, and median age was 68 years (range 41-78). Median disease course (time from onset of symptoms to death) was 22 days (range 5-44 days). In 11 patients tested for SARS-CoV-2 tropism, SARS-CoV-2 infected cells were present in multiple organs, most abundantly in the lungs, but presence in the lungs became sporadic with increased disease course. Other SARS-CoV-2-positive organs included the upper respiratory tract, heart, kidneys, and gastrointestinal tract. In histological analyses of organs (sampled from nine to 21 patients per organ), an extensive inflammatory response was present in the lungs, heart, liver, kidneys, and brain. In the brain, extensive inflammation was seen in the olfactory bulbs and medulla oblongata. Thrombi and neutrophilic plugs were present in the lungs, heart, kidneys, liver, spleen, and brain and were most frequently observed late in the disease course (15 patients with thrombi, median disease course 22 days [5-44]; ten patients with neutrophilic plugs, 21 days [5-44]). Neutrophilic plugs were observed in two forms: solely composed of neutrophils with neutrophil extracellular traps (NETs), or as aggregates of NETs and platelets..

INTERPRETATION

In patients with lethal COVID-19, an extensive systemic inflammatory response was present, with a continued presence of neutrophils and NETs. However, SARS-CoV-2-infected cells were only sporadically present at late stages of COVID-19. This suggests a maladaptive immune response and substantiates the evidence for immunomodulation as a target in the treatment of severe COVID-19.

FUNDING

Amsterdam UMC Corona Research Fund.

摘要

背景

严重急性呼吸综合征冠状病毒 2(SARS-CoV-2)靶向多个器官并导致严重的凝血功能障碍。组织病理学器官变化不仅归因于直接的病毒诱导作用,还归因于免疫反应。本研究的目的是评估病毒存在的持续时间,确定炎症反应的程度,并研究凝血功能障碍的根本原因。

方法

这是一项在荷兰阿姆斯特丹大学医学中心(UMC)进行的前瞻性尸检队列研究。征得亲属同意后,对 21 名因 COVID-19 要求进行尸检的患者进行了全身尸检,这些患者的尸检时间为 2020 年 3 月 9 日至 5 月 18 日之间。除了对器官损伤进行组织病理学评估外,还评估了 SARS-CoV-2 核衣壳蛋白的存在以及免疫浸润物和血栓的组成,并将所有这些都与疾病过程相关联。

发现

我们的队列(n=21)包括 16 名(76%)男性,中位年龄为 68 岁(范围 41-78 岁)。中位疾病病程(从症状发作到死亡的时间)为 22 天(范围 5-44 天)。在 11 名接受 SARS-CoV-2 嗜性检测的患者中,SARS-CoV-2 感染细胞存在于多个器官中,在肺部最为丰富,但随着疾病病程的延长,肺部的 SARS-CoV-2 感染细胞变得稀少。其他 SARS-CoV-2 阳性器官包括上呼吸道、心脏、肾脏和胃肠道。在对 9 至 21 名患者/器官的组织进行的器官组织学分析中,肺部、心脏、肝脏、肾脏和大脑均存在广泛的炎症反应。在大脑中,嗅球和延髓中可见广泛的炎症。在肺部、心脏、肾脏、肝脏、脾脏和大脑中均可见血栓和嗜中性粒细胞栓子,并且在疾病后期(15 例有血栓,病程中位数 22 天[5-44];10 例有嗜中性粒细胞栓子,病程 21 天[5-44])最常观察到。嗜中性粒细胞栓子有两种形式:仅由嗜中性粒细胞和细胞外陷阱(NETs)组成,或由 NETs 和血小板组成的聚集物。

解释

在患有致命 COVID-19 的患者中,存在广泛的全身炎症反应,同时持续存在嗜中性粒细胞和 NETs。然而,在 COVID-19 的晚期仅偶尔存在 SARS-CoV-2 感染细胞。这表明存在适应性免疫反应不良,并证实免疫调节是治疗严重 COVID-19 的目标。

资金

阿姆斯特丹 UMC 科罗娜研究基金。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e9cf/7518879/e62f3371a442/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e9cf/7518879/44ed08fc484e/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e9cf/7518879/19c8984fe727/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e9cf/7518879/07bb6ed97e79/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e9cf/7518879/e62f3371a442/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e9cf/7518879/44ed08fc484e/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e9cf/7518879/19c8984fe727/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e9cf/7518879/07bb6ed97e79/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e9cf/7518879/e62f3371a442/gr4.jpg

相似文献

1
Viral presence and immunopathology in patients with lethal COVID-19: a prospective autopsy cohort study.在致死性 COVID-19 患者中的病毒存在和免疫病理学:一项前瞻性尸检队列研究。
Lancet Microbe. 2020 Nov;1(7):e290-e299. doi: 10.1016/S2666-5247(20)30144-0. Epub 2020 Sep 25.
2
Autopsy Findings and Venous Thromboembolism in Patients With COVID-19: A Prospective Cohort Study.COVID-19 患者的尸检结果与静脉血栓栓塞:一项前瞻性队列研究。
Ann Intern Med. 2020 Aug 18;173(4):268-277. doi: 10.7326/M20-2003. Epub 2020 May 6.
3
Immunothrombotic Dysregulation in COVID-19 Pneumonia Is Associated With Respiratory Failure and Coagulopathy.新型冠状病毒肺炎肺炎中的免疫血栓调节紊乱与呼吸衰竭和凝血病有关。
Circulation. 2020 Sep 22;142(12):1176-1189. doi: 10.1161/CIRCULATIONAHA.120.048488. Epub 2020 Jul 28.
4
Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.COVID-19 住院成人患者使用伊马替尼的安全性和疗效:一项随机对照试验研究方案的结构化总结。
Trials. 2020 Oct 28;21(1):897. doi: 10.1186/s13063-020-04819-9.
5
Histopathological findings and viral tropism in UK patients with severe fatal COVID-19: a post-mortem study.英国重症致死 COVID-19 患者的组织病理学发现和病毒嗜性:一项尸检研究。
Lancet Microbe. 2020 Oct;1(6):e245-e253. doi: 10.1016/S2666-5247(20)30115-4. Epub 2020 Aug 20.
6
High Levels of Neutrophil Extracellular Traps Persist in the Lower Respiratory Tract of Critically Ill Patients With Coronavirus Disease 2019.高水平的中性粒细胞胞外诱捕网持续存在于 2019 年冠状病毒病危重症患者的下呼吸道中。
J Infect Dis. 2021 May 20;223(9):1512-1521. doi: 10.1093/infdis/jiab050.
7
Evidence of Severe Acute Respiratory Syndrome Coronavirus 2 Replication and Tropism in the Lungs, Airways, and Vascular Endothelium of Patients With Fatal Coronavirus Disease 2019: An Autopsy Case Series.严重急性呼吸综合征冠状病毒 2 在 COVID-19 死亡患者肺部、气道和血管内皮中的复制和嗜性的证据:一项尸检病例系列研究。
J Infect Dis. 2021 Mar 3;223(5):752-764. doi: 10.1093/infdis/jiab039.
8
Post-mortem viral dynamics and tropism in COVID-19 patients in correlation with organ damage.新冠肺炎患者死后病毒动力学和嗜性与器官损伤的相关性研究。
Virchows Arch. 2021 Feb;478(2):343-353. doi: 10.1007/s00428-020-02903-8. Epub 2020 Aug 20.
9
Early postmortem mapping of SARS-CoV-2 RNA in patients with COVID-19 and the correlation with tissue damage.COVID-19 患者死后早期 SARS-CoV-2 RNA 定位及其与组织损伤的相关性。
Elife. 2021 Mar 30;10:e60361. doi: 10.7554/eLife.60361.
10
Association Between SARS-CoV-2 Infection and Immune-Mediated Myopathy in Patients Who Have Died.死于 SARS-CoV-2 感染和免疫介导性肌病的患者之间的关联。
JAMA Neurol. 2021 Aug 1;78(8):948-960. doi: 10.1001/jamaneurol.2021.2004.

引用本文的文献

1
Neutrophil Extracellular Trap Markers in Post Mortem Lung Biopsies from COVID-19 Patients.新冠病毒肺炎患者尸检肺活检中的中性粒细胞胞外诱捕网标志物
Int J Mol Sci. 2025 Aug 20;26(16):8059. doi: 10.3390/ijms26168059.
2
A data-mining analysis of host solute carrier family proteins in SARS-CoV-2 infection with reference to brain endothelial cells and the blood-brain barrier in COVID-19.参照新冠病毒感染中脑内皮细胞和血脑屏障对严重急性呼吸综合征冠状病毒2感染中宿主溶质载体家族蛋白的数据挖掘分析。
Front Neurol. 2025 Jul 1;16:1563040. doi: 10.3389/fneur.2025.1563040. eCollection 2025.
3
APOE genotype confers context-dependent neurovascular vulnerability in immune-vascularized human forebrain organoids.

本文引用的文献

1
Outcomes of Cardiovascular Magnetic Resonance Imaging in Patients Recently Recovered From Coronavirus Disease 2019 (COVID-19).COVID-19 患者近期康复后的心血管磁共振成像结果。
JAMA Cardiol. 2020 Nov 1;5(11):1265-1273. doi: 10.1001/jamacardio.2020.3557.
2
Association of Cardiac Infection With SARS-CoV-2 in Confirmed COVID-19 Autopsy Cases.心脏感染与确诊 COVID-19 尸检病例中 SARS-CoV-2 的关联。
JAMA Cardiol. 2020 Nov 1;5(11):1281-1285. doi: 10.1001/jamacardio.2020.3551.
3
Dexamethasone in Hospitalized Patients with Covid-19.
载脂蛋白E(APOE)基因型在免疫血管化的人类前脑类器官中赋予了依赖于背景的神经血管易损性。
bioRxiv. 2025 May 9:2025.05.08.652864. doi: 10.1101/2025.05.08.652864.
4
Thromboinflammation vs. immunothrombosis: strategies for overcoming anticoagulant resistance in COVID-19 and other hyperinflammatory diseases. Is ROTEM helpful or not?血栓炎症与免疫血栓形成:克服COVID-19和其他高炎症性疾病中抗凝抵抗的策略。旋转血栓弹力图(ROTEM)是否有用?
Front Immunol. 2025 Jun 19;16:1599639. doi: 10.3389/fimmu.2025.1599639. eCollection 2025.
5
Temporal multi-omics analysis of COVID-19 in end-stage kidney disease.终末期肾病患者新冠病毒病的时间多组学分析
Cell Genom. 2025 Aug 13;5(8):100918. doi: 10.1016/j.xgen.2025.100918. Epub 2025 Jun 17.
6
Post-COVID-19 condition: clinical phenotypes, pathophysiological mechanisms, pathology, and management strategies.新冠后状况:临床表型、病理生理机制、病理学及管理策略
J Pathol. 2025 Aug;266(4-5):369-389. doi: 10.1002/path.6443. Epub 2025 Jun 10.
7
Characterising dysfunctional breathing seen in post-acute sequelae of SARS-CoV-2 using approximate entropy.使用近似熵来表征新冠病毒急性后遗症中出现的呼吸功能障碍。
ERJ Open Res. 2025 Jun 2;11(3). doi: 10.1183/23120541.00652-2024. eCollection 2025 May.
8
Identification of Early Biomarkers of Mortality in COVID-19 Hospitalized Patients: A LASSO-Based Cox and Logistic Approach.COVID-19住院患者死亡早期生物标志物的识别:基于LASSO的Cox和Logistic方法
Viruses. 2025 Feb 28;17(3):359. doi: 10.3390/v17030359.
9
SARS-CoV-2 cellular coinfection is limited by superinfection exclusion.严重急性呼吸综合征冠状病毒2型(SARS-CoV-2)的细胞共感染受超感染排斥限制。
J Virol. 2025 Apr 15;99(4):e0207724. doi: 10.1128/jvi.02077-24. Epub 2025 Mar 21.
10
Host Response Protein Biomarkers Indicative of Persistent Acute Kidney Injury in Critically Ill COVID-19 Patients.提示危重症COVID-19患者持续性急性肾损伤的宿主反应蛋白生物标志物
Crit Care Explor. 2025 Mar 13;7(3):e1222. doi: 10.1097/CCE.0000000000001222. eCollection 2025 Mar 1.
地塞米松在 COVID-19 住院患者中的应用。
N Engl J Med. 2021 Feb 25;384(8):693-704. doi: 10.1056/NEJMoa2021436. Epub 2020 Jul 17.
4
Neuropathological Features of Covid-19.新冠病毒病的神经病理学特征
N Engl J Med. 2020 Sep 3;383(10):989-992. doi: 10.1056/NEJMc2019373. Epub 2020 Jun 12.
5
Pulmonary post-mortem findings in a series of COVID-19 cases from northern Italy: a two-centre descriptive study.意大利北部一系列 COVID-19 病例的肺脏尸检结果:一项两中心描述性研究。
Lancet Infect Dis. 2020 Oct;20(10):1135-1140. doi: 10.1016/S1473-3099(20)30434-5. Epub 2020 Jun 8.
6
Early evidence of pronounced brain involvement in fatal COVID-19 outcomes.有明显脑部受累与COVID-19致命结局相关的早期证据。
Lancet. 2020 Jun 20;395(10241):e109. doi: 10.1016/S0140-6736(20)31282-4. Epub 2020 Jun 4.
7
Pulmonary and cardiac pathology in African American patients with COVID-19: an autopsy series from New Orleans.非裔美国人 COVID-19 患者的肺部和心脏病理学:来自新奥尔良的尸检系列。
Lancet Respir Med. 2020 Jul;8(7):681-686. doi: 10.1016/S2213-2600(20)30243-5. Epub 2020 May 27.
8
Pulmonary and systemic involvement in COVID-19 patients assessed with ultrasound-guided minimally invasive autopsy.超声引导下微创尸检评估COVID-19患者的肺部和全身受累情况。
Histopathology. 2020 Aug;77(2):186-197. doi: 10.1111/his.14160. Epub 2020 Jul 24.
9
Pulmonary Vascular Endothelialitis, Thrombosis, and Angiogenesis in Covid-19.新型冠状病毒肺炎的肺血管内皮细胞炎症、血栓形成和血管生成。
N Engl J Med. 2020 Jul 9;383(2):120-128. doi: 10.1056/NEJMoa2015432. Epub 2020 May 21.
10
Postmortem Examination of Patients With COVID-19.COVID-19 患者的尸检。
JAMA. 2020 Jun 23;323(24):2518-2520. doi: 10.1001/jama.2020.8907.